IRIS Accounts Production v24.3.2.46 SC448214 director 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4482142023-04-30SC4482142024-04-30SC4482142023-05-012024-04-30SC4482142022-04-30SC4482142022-05-012023-04-30SC4482142023-04-30SC448214ns15:Scotland2023-05-012024-04-30SC448214ns14:PoundSterling2023-05-012024-04-30SC448214ns10:Director12023-05-012024-04-30SC448214ns10:PrivateLimitedCompanyLtd2023-05-012024-04-30SC448214ns10:SmallEntities2023-05-012024-04-30SC448214ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-30SC448214ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-30SC448214ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-30SC448214ns10:FullAccounts2023-05-012024-04-30SC448214ns10:RegisteredOffice2023-05-012024-04-30SC448214ns5:CurrentFinancialInstruments2024-04-30SC448214ns5:CurrentFinancialInstruments2023-04-30SC448214ns5:Non-currentFinancialInstruments2024-04-30SC448214ns5:Non-currentFinancialInstruments2023-04-30SC448214ns5:ShareCapital2024-04-30SC448214ns5:ShareCapital2023-04-30SC448214ns5:RetainedEarningsAccumulatedLosses2024-04-30SC448214ns5:RetainedEarningsAccumulatedLosses2023-04-30SC448214ns5:FurnitureFittings2023-05-012024-04-30SC448214ns5:FurnitureFittings2023-04-30SC448214ns5:FurnitureFittings2024-04-30SC448214ns5:FurnitureFittings2023-04-30SC448214ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-30SC448214ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30SC4482141ns10:Director12023-04-30SC4482141ns10:Director12022-04-30SC4482141ns10:Director12023-05-012024-04-30SC4482141ns10:Director12022-05-012023-04-30SC4482141ns10:Director12024-04-30SC4482141ns10:Director12023-04-30
REGISTERED NUMBER: SC448214 (Scotland)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024

FOR

BN MEDICAL LTD

BN MEDICAL LTD (REGISTERED NUMBER: SC448214)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BN MEDICAL LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTOR: B B S Brad





REGISTERED OFFICE: 9-11 Palacecraig Street
Coatbridge
Lanarkshire
ML5 4RY





REGISTERED NUMBER: SC448214 (Scotland)





ACCOUNTANTS: McDaid & Partners
Stanley House
69/71 Hamilton Road
Motherwell
Lanarkshire
ML1 3DG

BN MEDICAL LTD (REGISTERED NUMBER: SC448214)

BALANCE SHEET
30 APRIL 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,719 2,022

CURRENT ASSETS
Stocks 1,594 3,000
Debtors 5 25,924 71,835
Cash at bank 7 7
27,525 74,842
CREDITORS
Amounts falling due within one year 6 61,122 57,881
NET CURRENT (LIABILITIES)/ASSETS (33,597 ) 16,961
TOTAL ASSETS LESS CURRENT
LIABILITIES

(31,878

)

18,983

CREDITORS
Amounts falling due after more than one
year

7

(9,129

)

(41,181

)

PROVISIONS FOR LIABILITIES (327 ) (384 )
NET LIABILITIES (41,334 ) (22,582 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (41,434 ) (22,682 )
(41,334 ) (22,582 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BN MEDICAL LTD (REGISTERED NUMBER: SC448214)

BALANCE SHEET - continued
30 APRIL 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 January 2025 and were signed by:





B B S Brad - Director


BN MEDICAL LTD (REGISTERED NUMBER: SC448214)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

BN Medical Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is stated net of VAT and trade discounts. Turnover from the sale of goods is recognised when the goods are completed. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the value of the consideration due. Where the contract has only been partially completed at the balance sheet date turnover represents the value of the service provided to date based on a proportion of the total contract value. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures & fittings - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Trade debtors
Trade debtors are amounts due from customers for goods or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade Creditors
Trade creditors are amounts due to suppliers for goods or services obtained in the ordinary course of business.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Cash
Cash and cash equivalents are basic financial assets and include cash on hand, deposits held at call with banks, other short-term liquid investments and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.


BN MEDICAL LTD (REGISTERED NUMBER: SC448214)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The company will continue to trade with the ongoing support of the director.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
& fittings
£   
COST
At 1 May 2023
and 30 April 2024 7,585
DEPRECIATION
At 1 May 2023 5,563
Charge for year 303
At 30 April 2024 5,866
NET BOOK VALUE
At 30 April 2024 1,719
At 30 April 2023 2,022

BN MEDICAL LTD (REGISTERED NUMBER: SC448214)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 21,104 30,469
Other debtors 4,820 41,366
25,924 71,835

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans and overdrafts 34,496 30,443
Trade creditors 15,102 12,745
Taxation and social security 313 1,922
Other creditors 11,211 12,771
61,122 57,881

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.4.24 30.4.23
£    £   
Bank loans 9,129 41,181

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 April 2024 and 30 April 2023:

30.4.24 30.4.23
£    £   
B B S Brad
Balance outstanding at start of year (3,248 ) (1,871 )
Amounts advanced 23,469 25,206
Amounts repaid (20,221 ) (26,583 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - (3,248 )

Loans to/from the director are interest free and repayable on demand.

9. RELATED PARTY DISCLOSURES

Burlington Scott (Scotland) Limited is a related party by virtue of B B S Brad being a director in both companies. Included within other debtors is a balance due to the company of £674 (2023 £33,303).

B S (Coatbridge) Properties Limited is a related party by virtue of B B S Brad being a director in both companies. Included within other creditors is a balance from the company of £5,281 (2023 £6,856).




10. LEASING AGREEMENTS

The total amount of lease commitments is £68,800 (2023 £78,400).